CCM
PTCT icon

Cupps Capital Management’s PTC Therapeutics PTCT Stock Holding History

Cupps Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-109,770
Closed -$6.68M – 210
2015
Q1 		$6.68M Sell
109,770
-25,304
-19% -$1.54M 0.59% 65
2014
Q4 		$6.99M Sell
135,074
-30,502
-18% -$1.34M 0.63% 53
2014
Q3 		$7.29M Buy
+165,576
New +$5.18M 0.67% 57

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Cupps Capital Management's PTCT Position: Q2 2015 in Review

Cupps Capital Management sold out of PTC Therapeutics (PTCT) in Q2 2015, closing a stake of 109,770 shares — an estimated $6.68M sold.

Cupps Capital Management first reported a position in PTCT in Q3 2014 and held it in 3 quarters. The position peaked at $7.29M in Q3 2014. 155 funds tracked by Wall St. Rank hold PTCT as of Q2 2015.

  • Cupps Capital Management reported no remaining PTC Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Cupps Capital Management sold 109,770 PTC Therapeutics shares in Q2 2015, an estimated $6.68M.
  • Cupps Capital Management first reported a position in PTC Therapeutics in Q3 2014 and held it in 3 quarters.
  • Cupps Capital Management's PTC Therapeutics position peaked at $7.29M in Q3 2014.
  • 155 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2015.

Based on Cupps Capital Management's 13F filing for Q2 2015, filed 6 Aug 2015.